RxDoctor Payments Data

Lori Staudenmaier, DO

Family Medicine · Knoxville, TNNPI 1063767093

Payments from drug & device makers

$523in general payments, 2019–2025

Across 28 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$178
  • Novo Nordisk$141
  • Amgen$47
  • Boehringer Ingelheim$41
  • AbbVie$38
  • Medtronic$35
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$50496%
  • Education$194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$523 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$135,386
Medicare patients
204
Services billed
4,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$43,591
XareltoRivaroxaban45$38,924
EliquisApixaban26$38,747
MounjaroTirzepatide24$34,467
JardianceEmpagliflozin28$31,503
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$30,218
Repatha SureclickEvolocumab16$10,669
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$10,591
ShingrixVaricella-Zoster Ge/As01b/Pf32$7,159
SymbicortBudesonide/Formoterol Fumarate20$6,317
Rosuvastatin Calcium292$2,618
Levothyroxine Sodium293$2,055
Atorvastatin Calcium249$1,990
Albuterol Sulfate HfaAlbuterol Sulfate62$1,745
SynthroidLevothyroxine Sodium38$1,391

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$141$43,59129 claims
GSKTrelegy Ellipta, Shingrix$178$37,37748 claims
Boehringer IngelheimJardiance$41$31,50328 claims
AbbVieSynthroid$38$1,39138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →